LORINDEN A

This brand name is authorized in Lithuania, Poland

Active ingredients

The drug LORINDEN A contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Flumetasone UNII `LR3CD8SX89` - FLUMETHASONE
	Read more about Flumetasone
`2`	Salicylic acid UNII `O414PZ4LPZ` - SALICYLIC ACID
	Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium.
	Read more about Salicylic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D07XB01	Flumetasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XB Corticosteroids, moderately potent, other combinations
Discover more medicines within D07XB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
LT	Valstybinė vaistų kontrolės tarnyba	1010797
PL	Rejestru Produktów Leczniczych	100039743, 100125767, 100295920, 100344771, 100362450, 100365483, 100373896, 100400140, 100407603, 100408726, 100423476, 100438101, 100455134

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.